LUNGevity Celebration of HOPE Program - Other - Page 45
30% to 49%
49%
30%
of patients who undergo genomic cancer
testing have actionable alterations.
These results can paint a more precise picture of
your cancer and may impact treatment decisions.
Visit TestYourCancer.com to learn more
about how genomic cancer testing
can change your treatment journey.
© 2020 Bayer. Bayer and the Bayer Cross are registered trademarks of Bayer | PP-PF-ONC-US-1489-1
Johns Hopkins
Radiation Oncology
the efforts of
Johns Hopkins Supports and applaudsSusan
F. Stinson, MD
Stephen C Greco, MD
Radiation Oncology
Brandi R. Page, MD
The LUNGevity Foundation
at Suburban Hospital
Amanda Walker, MD
Susan F. Stinson, MD
Stephen C. Greco, MD
Laurie L. Herscher, MD
Supports and applauds
Appointments:
the efforts of
410-502-8000
LUNGevity Foundation
Appointments
410-502-8000
hopkinsmedicine.org
hopkinsmedicine.org